Status of “Substantial Implementation”: Mid-2016. In our earlier client alerts, SEC Releases Additional No-Action Letters On “Substantial Implementation” Of Shareholder Proxy Access Proposals (March ...

The withdrawal of these no action letters opens up for discussion, and creates uncertainty around, the circumstances in which investors may rely on proxy advisory firm recommendations and when a firm ...

Details Track Record of Poor Performance, Weak Execution, and Flawed Governance Under CEO & Chairman Jochen Zeitz, Presiding Director Thomas Linebarger, and Long-Tenured Director Sara Levinson ...

EQT Files Definitive Proxy and Mails Letter to Shareholders Highlights Success of New EQT Board, Leadership Team and Ambitious, Realistic Strategic Plan Already Delivering Clear Results Urges Support ...

Kohl’s Board and management team are producing strong results and continuing to successfully execute on the Company’s long-term strategy Kohl’s Board is committed to evaluating opportunities to ...

HONOLULU, March 02, 2020 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (“Barnwell” or the “Company”) (NYSE American: BRN) today announced that it has filed definitive proxy materials with the U.S.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (“American Vanguard” or “the Company”) (NYSE:AVD) today announced that it has filed its definitive proxy statement with the U.S.

Lululemon Athletica’s proxy fight is heating up, as founder Chip Wilson ramps up the pressure for change at the company’s board of directors. On Friday, Wilson issued his first shareholder letter of ...

Bath & Body Work’s board of directors has slammed activist investor Third Point’s proxy challenge as “misguided,” suggesting that it is because the retailer rejected Third Point’s “ultimatum” that it ...

Highlights strategic progress, improving results and the Board’s multi-year evolution Urges shareholders to vote “FOR” ONLY WEX’s nine highly qualified nominees using the BLUE proxy card PORTLAND, ...

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and ...